Take control of your epilepsy and seizures. Seizure management has never been easier.
TAKE CONTROL TODAY
Rashes that may be more serious are more likely to occur in persons with a particular gene called “HLA-B*1502”. This gene occurs almost exclusively in patients with ancestry across broad areas of Asia, including South Asian Indians. Patients with ancestry from these areas should have a blood test to see if they have the “HLA-B*1502” gene before starting treatment. Further Information for Healthcare Professionals Related to this Topic:
http://www.fda.gov/cder/drug/InfoSheets/HCP/carbamazepineHCP.htm
Carbamazepine should be started at 100-200 mg per day and titrated by increments of 100-200 mg every week or two as clinically needed. The average maintenance dose as monotherapy for adults is 600-1200 mg per day. In children over 6, the usual maintenance dose is 15-30 mg/kg per day. The dosage may need to be increased within a month of initiation due to autoinduction. (See Clinical pharmacology.)
Many people (especially children) need to take carbamazepine in three or four doses a day. The extended-release forms, Tegretol-XR and Carbatrol, are often preferable for patients who have trouble with compliance and for those whose blood levels fluctuate widely throughout the day.
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.
